You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



An Expert Perspective: Managing Advanced/Recurrent Endometrial Cancer

  • Authors: Ana Oaknin, MD, PhD
  • CME / ABIM MOC Released: 11/8/2022
  • Valid for credit through: 11/8/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for oncologists, obstetricians/gynecologists, pathologists, and other clinicians involved in care of individuals with endometrial cancer.

The goal of this activity is for learners to be better able to care for patients with endometrial cancer who are being treated with immunotherapy-based therapies and those who are eligible for maintenance therapy.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data for immunotherapies in patients with advanced endometrial cancer
    • Appropriate immunotherapy management strategies for patients with advanced endometrial cancer


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


  • Ana Oaknin, MD, PhD

    Principal Investigator
    Gynecologic Malignancies Group
    Vall d'Hebron Institute of Oncology (VHIO)
    Head of Gynecologic Tumors Unit
    Vall d'Hebron University Hospital
    Barcelona, Spain


    Ana Oaknin, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Agenus; AstraZeneca; Clovis Oncology, Inc.; Corcept Therapeutics; Deciphera Pharmaceutical; Eisai Europe Limited; EMD Serono, Inc.; F. Hoffmann-La Roche; GlaxoSmithKline; Immunogen; KL Logistics; Medison Pharma; Merck Sharp & Dohme de España; Mersana Therapeutics; Novocure GmbH; Pharma Mar; prIME Oncology; Roche Farma; Shattuck Labs; Sutro Biopharma, Inc.
    Research funding from: Paid directly to my institution: AbbVie Deutschland GmbH & Co KG; Ability Pharmaceuticals; Advaxis; Agenus; Aprea Therapeutics AB; AstraZeneca AB; BeiGene USA, Inc.; Bristol Myers Squibb International Corporation (BMS); Clovis Oncology; Corcept Therapeutics; Eisai; F. Hoffmann-La Roche; Immunogen; Iovance Biotherapeutics; Lilly; Medimmune; Merck Healthcare; Merck Sharp & Dohme; Millennium Pharmaceuticals; Mundipharma Research; Novartis Farmacéutica; Regeneron Pharmaceuticals; Seagen Inc.; Sutro Biopharma, Inc.; Tesaro; Verastem


  • Charlotte Warren

    Senior Director, Content Development, Medscape, LLC


    Charlotte Warren has no relevant financial relationships.

  • Jason Luis Quiñones, PhD

    Scientific Content Manager, Medscape, LLC


    Jason Luis Quiñones, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer:

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


An Expert Perspective: Managing Advanced/Recurrent Endometrial Cancer

Authors: Ana Oaknin, MD, PhDFaculty and Disclosures

CME / ABIM MOC Released: 11/8/2022

Valid for credit through: 11/8/2023, 11:59 PM EST


Learning Feedback Questions

Before you begin, please take this brief survey. 

  • Print